Is MIR a Buy or a Sell? The Bull and Bear Case (2026)

That depends on which case you find more convincing, and both are on this page. The bull case rests on Nuclear power tailwind, with revenue (fy2025) at ~$925M. The bear case rests on mirion has a history of GAAP net losses, and reported earnings remain thin relative to its valuation, so much of the story depends on adjusted figures. Analysts covering it are spread from $25.00 to $29.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. Mirion has a history of GAAP net losses, and reported earnings remain thin relative to its valuation, so much of the story depends on adjusted figures. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $25.00, +65.5% from the $15.11 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.

Nuclear power tailwind. Renewed global interest in nuclear energy, including plant life extensions, new builds and small modular reactors, drives demand for Mirion's detection and safety instrumentation. The most optimistic analyst target on MIR is $29.00, +91.9% from the $15.11 price. That figure is only reachable if this thesis works close to its best case.

Mirion has a history of GAAP net losses, and reported earnings remain thin relative to its valuation, so much of the story depends on adjusted figures. The balance sheet carries meaningful debt (around $1.2 billion) and interest expense, which pressures net income and adds sensitivity to rates. Growth leans on acquisitions, creating integration, goodwill and execution risk. Nuclear project timing can be lumpy and dependent on government funding and utility capital budgets, and a large share of revenue ties to a niche end market. The shares have been volatile, down meaningfully year to date at points in 2026 even after strong quarterly orders. The most pessimistic published target is $25.00, +65.5% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.

Mirion Technologies (NYSE: MIR) designs and sells radiation detection, measurement, analysis and monitoring products across two segments: Nuclear & Safety, which serves nuclear pow

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Nuclear power tailwind) stalling in the reported numbers rather than in the narrative, the risk above (mirion has a history of GAAP net losses, and reported earnings remain thin relative to its valuation, so much of the story depends on adjusted figures) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

Mirion makes radiation detection, measurement, analysis and monitoring equipment and services. It serves nuclear power plants, defense, research labs and industrial users through its Nuclear & Safety segment and cancer-care and diagnostics customers through its Medical segment.

MIR is the New York Stock Exchange ticker for Mirion Technologies, Inc. The company became publicly traded in 2021 through a merger with a special purpose acquisition company (SPAC).

Mirion generates positive operating income and adjusted EBITDA, but it has reported GAAP net losses driven by amortization and high interest expense. Investors often focus on adjusted EBITDA and free cash flow rather than reported net income.